See below our active Generic Files :
|
Product |
DMF/ASMF |
CEP |
Country |
|
1,3,5-Trimethoxybenzene |
♦ |
|
Italy |
|
Acetohydroxamic acid |
♦ |
|
USA |
|
Amiodarone hydrochloride |
♦ |
♦ |
Australia, Canada, Europe, USA |
|
Diosmine |
♦ |
♦ |
Europe, Singapore, Spain, USA |
|
Domiphen bromide |
♦ |
|
UK, USA |
|
Econazole nitrate |
♦ |
|
Belgium, France, Italy, USA |
|
Indoramine hydrochloride |
♦ |
|
Ireland, UK, USA |
|
Loperamide hydrochloride |
♦ |
|
Canada, France, USA |
|
Naftazone |
♦ |
|
Belgium, France, Switzerland |
|
Nefopam hydrochloride |
♦ |
|
Canada, France, Ireland, UK, USA |
|
Nifuroxazide |
♦ |
|
Belgium, France |
|
Pantoprazole sodium sesquihydrate |
♦ |
♦ |
Europe, USA |
|
Tertiobutylchlorobutyrophenone |
♦ |
|
USA |
|
Tocofersolan ( Vit. E TPGS ) |
♦ | Europe, USA | |
|
Trimebutine base |
♦ |
|
France |
|
Trimebutine maleate |
♦ |
♦ |
Canada, Europe, France, Italy, USA |
REACH
« One of the main objectives of REACH Regulation is to increase and promote innovation by providing encouragement to innovate for research-orientated companies » (From ECHA November 2014 – Guidance on Scientific R&D (SR&D) and Product and Process Orientated Research and Development (PPORD)).
Deeply involved in REACH Regulation, PMC Isochem has submitted:
-
~ 300 pre-registrations
-
~ 19 registrations available on ECHA website
-
16 PPORD
In cooperation with UIC and SICOS councils, PMC Isochem also notifies intermediates manufactured under strictly controlled conditions for the protection of workers and the environment.
